MosaMeat BV closes US$85m Series B financing

While EU policymakers are yet discussing the green deal or farm to fork strategies, Dutch MosaMeat BV is launching a new era of biotechnologically produced meat. Instead of slaughtering animals, the company just takes a biopsy of 0.5g from cattle, cultures the 30,000 myosatellite cells included into trillions of muscle cells in fermenters, giving 80,000 burger patties out of just one sample – without any need for agricultural area, antibiotics, GMO soybean supplements in feedstuff.

At the end of February, MosaMeat neared that vision closing a Series B financing  led by Luxembourg-based Blue Horizon Ventures at US$85m. According to the company it will “enable us to extend our current pilot production facility in Maastricht, develop an industrial-sized production line, expand our team, and introduce "delicious cultivated beef to consumer".